1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Evaluation of immune infiltration in a population-based cohort of diffuse large B-cell lymphoma
- Master (Two yrs)
- 2024
-
Mark
Workflows for the analysis of transcriptomic data at single-cell and spatial resolutions: T cells in lymphoma
- Master (Two yrs)
-
Mark
Prognostic impact of CD163 and CD11c in B cell lymphomas
- Master (Two yrs)
- 2023
-
Mark
The Frequency and Biological Impact of CD25 Expression in Mantle Cell Lymphoma
- Master (Two yrs)
-
Mark
Evaluating targeted combination therapies in EGFR wild-type non-small-cell lung cancer using mass spectrometry-based proteomics
- Master (Two yrs)
-
Mark
Multi-omics integration of spatially resolved transcriptome and proteome data in mantle cell lymphoma
- Master (Two yrs)
- 2022
-
Mark
PLK-1 inhibition has a functional impact on MYC and is a relevant target for high-risk mantle cell lymphoma patients
- Master (Two yrs)
- 2021
-
Mark
Drug-induced response and antibody-dependent cellular cytotoxicity in microfluidic cultures with dynamic flow
- Master (Two yrs)
-
Mark
Analysis of Myc Aberrations in Mantle Cell Lymphoma and Drug Target Identification
- Master (Two yrs)
-
Mark
DLBCL Patient stratification using serum protein profiling
- Master (Two yrs)